Dexcom (DXCM) EBITDA Margin (2010 - 2026)
Dexcom's (DXCM) quarterly EBITDA Margin came in at 24.33% in Q2 2026, up 595.0% year-over-year from 3.5% in Q2 2025, and up 13.58% quarter-over-quarter from 21.42% in Q1 2026.
Powered by 
Analysis
Dexcom (DXCM) EBITDA Margin (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported EBITDA Margin for 17 consecutive years, with 24.33% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 595.0% year-over-year to 24.33% in Q2 2026; TTM through Jun 2026 was 22.92%, a 694.0% increase from a year earlier, with the FY2025 full-year figure at 19.56%, up 468.0% from the prior year.
- EBITDA Margin was 24.33% for Q2 2026 at Dexcom, up from 21.42% in the prior quarter.
- Over five years, EBITDA Margin peaked at 25.64% in Q4 2025 and troughed at 6.37% in Q1 2023.
- A 5-year average of 16.5% and a median of 16.35% in 2024 frame the typical range for EBITDA Margin.
- The widest YoY moves for EBITDA Margin: up 1530 bps in 2022, down 591 bps in 2022.
- Over 5 years, EBITDA Margin stood at 15.38% in 2022, then jumped by 36 bps to 20.97% in 2023, then slipped by 19 bps to 16.96% in 2024, then jumped by 51 bps to 25.64% in 2025, then fell by 5 bps to 24.33% in 2026.
- The last three EBITDA Margin figures came in at 24.33% (Q2 2026), 21.42% (Q1 2026), and 25.64% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.51 Bn | 177.91 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 124.70 Bn | 119.48 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.95 Bn | 109.13 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 106.08 Bn | 102.61 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.53 Bn | 65.99 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.51 Bn | 45.26 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.90 Bn | 32.44 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.09 Bn | 30.14 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.06 Bn | 20.58 Bn | 684.20 Mn | 19.15% |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | 14.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.33% |
| Mar 31, 2026 | 21.42% |
| Dec 31, 2025 | 25.64% |
| Sep 30, 2025 | 20.05% |
| Jun 30, 2025 | 18.37% |
| Mar 31, 2025 | 12.91% |
| Dec 31, 2024 | 16.96% |
| Sep 30, 2024 | 15.29% |
| Jun 30, 2024 | 15.73% |
| Mar 31, 2024 | 10.98% |
| Dec 31, 2023 | 20.97% |
| Sep 30, 2023 | 21.08% |
| Jun 30, 2023 | 14.70% |
| Mar 31, 2023 | 6.37% |
| Dec 31, 2022 | 15.38% |
| Sep 30, 2022 | 19.17% |
| Jun 30, 2022 | 11.06% |
| Mar 31, 2022 | 6.57% |
| Dec 31, 2021 | 0.09% |
| Sep 30, 2021 | 18.19% |